Find a TenderPast planning notice
Published 17 Nov 2021, 10:54 GMT

Official UK procurement notice

Antiviral Drug Supply for COVID-19

Official notice

Authority: Department of Health & Social Care (Central government)

Goods
Sectors: Medical Devices & Pharma (33) Delivery: UK
Planned pipeline value£1pipeline notice, not a live tender
Tender notice expected 1 Apr 2022from the planned procurement notice

What is being bought

Published requirement description

The Department of Health and Social Care through the Antivirals Taskforce is seeking to commence market engagement to identify antiviral drugs effective at preventing the progression of COVID-19 in a home or community setting. The market engagement will be in the form of webinars held on Tuesday 23rd November 2021 and Tuesday 1st December 2021, small roundtable sessions and potential one-to-one meetings. Details for accessing these events can be found further down.Suppliers are invited to register their interest in this Prior Information Notice by completing a questionnaire downloaded from the Atamis platform.We ask that suppliers complete the questionnaire by 13:00 on Friday 22nd December 2021. Suppliers will not need to complete a questionnaire to attend the webinar sessions or roundtables. Those interested in a one-to-one meeting are requested to complete the questionnaire by 13:00 on 3rd December 2021 or sooner.

CPV: Medicinal products for the respiratory system · Various medicinal products

The lotProcurement structure

single lot · no lot value published
Lot #1The Antivirals Taskforce leads on identifying and deploying innovative COVID-19…Planned

The Antivirals Taskforce leads on identifying and deploying innovative COVID-19 antivirals to stop the infection spreading, speed up recovery time and reduce the likelihood of hospitalisation following infection. The Taskforce is seeking to build a diverse portfolio of antiviral candidates for future deployment in the UK healthcare system. The purpose of this Prior Information Notice is to assess and understand the COVID-19 antivirals market by gathering information through market engagement and to gain a more detailed understanding of the market. The Taskforce is seeking to gather information in respect of antivirals that can be deployed in a home or community setting, with the primary mechanism of action targeting the SARS-CoV-2 virus. Antiviral suppliers must provide evidence of their compound’s pharmacological properties and mechanism of action. Compounds should be either self-administered, or through a single dose administration by a healthcare professional. The compound should also be given in either post-exposure prophylaxis or very early post infection (targeting acute virus not immune response). The market engagement will take the form of two webinars held on Tuesday 23rd November 2021 and Tuesday 1st December 2021. These webinars will take interested suppliers through the requirement outlined in this Prior Information Notice and will provide an opportunity for suppliers to ask questions. Both webinars will cover the same content. To sign up to join either webinar please visit: www.eventbrite.co.uk/e/prior-information-… ↗ are inviting suppliers to register their interest in the PIN by downloading a questionnaire via the Atamis platform, and sending a completed version to ATF-PIN@dhsc.gov.uk by 13:00 on 22nd December 2021. Responses to this questionnaire will be kept in confidence and will inform the Taskforce’s market research. Suppliers are not required to fill out a questionnaire before attending the webinars above.Informational Roundtables - We are also looking to host informational roundtables with smaller groups of industry experts as part of our objective to gain more insight into the market. Any suppliers interested in taking part in a roundtable are invited to get in touch by 13:00 Friday, 3rd December 2021 via ATF-PIN@dhsc.gov.uk Suppliers are not required to fill out a questionnaire before attending a roundtable.One-to-One Meetings - We are also looking to offer one-to-one meetings with suppliers based on their responses to the questionnaire, should suppliers wish to discuss commercially sensitive information. If you would be interested in a one-to-one session, please download and complete the questionnaire by 13:00 on 3rd December 2021 and send to ATF-PIN@dhsc.gov.uk. We will get in touch directly with suppliers that complete the questionnaire by this date to offer one-to-one meetings. Please note if there is very high demand for one-to-one sessions and we are unable to accommodate all requests, we may be required to choose not to offer one-to-one meetings at all.Any information shared in the webinars, roundtables and one-to-one sessions, except where commercially sensitive for suppliers, will be shared with all suppliers via the Atamis platform after the market engagement period associated with this PIN closes on Wednesday 22nd December 2021. Additional information: If suppliers would be interested in a one-to-one meeting, they should complete the questionnaire by 13:00 GMT on Friday 3rd December 2021 and submit to ATF-PIN@dhsc.gov.uk

Delivery: UK · Department of Health and Social Care39 Victoria StreetLondon, SW1H 0EU

Procedure terms & legal framework

From the official record · publisher note attached
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Past planning notice
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
17 Nov 2021, 10:54 GMT
Last source update
17 Nov 2021, 10:54 GMT
FTS notice number
2021/S 000-028676
Classification (CPV)
Medicinal products for the respiratory systemVarious medicinal products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-02f773 Find a Tender

Publisher note: Select this link to access the Atamis system: https://health-family.force.com/s/Welcome Select 'View Live Opportunities' and then select the 'PIN and Market Engagement - Antiviral Drug Supply to Treat COVID-19'. If you have not already done so, you need to register your organisation as a supplier from here: https://health-family.force.com/s/Welcome. Once registered, you can view the PIN and the Questionnaire. The contract agreement would be for the benefit of the contracting authority, NHS bodies and other public bodies responsible for delivery of health-related services in the United Kingdom, the Crown Dependencies and British Overseas Territories. Although DHSC are issuing a PIN, this is in no way a commitment to proceed with a procurement, it is merely an indication that the Department would like to engage with the market with a view to running future open procurement exercises where possible.In addition to this not forming a commitment to proceed with a procurement, not engaging with DHSC in this exercise does not exclude any organisation from participating in any formal commercial process which may follow. Please note that by participating in this process, records of one-to-one conversations and Q&As will be kept to ensure a clearly auditable decision-making trail and for FOI requests. Any information shared by DHSC in the webinars, roundtables and one-to-one sessions, except where commercially sensitive for suppliers, will be shared with all suppliers via the Atamis platform after the market engagement period associated with this PIN closes on 22nd December 2021.

How it was run

Official notice

Timeline

17 Nov 2021 → 1 Apr 2022 · 2 dates
  1. Notice published
    17 Nov 2021, 10:54 GMT
  2. Tender notice expected
    1 Apr 2022, 00:00 BST

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

Department of Health and Social Care

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 39 Victoria Street, London, London, SW1H 0EUContact email

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.